Skip to main content

Published locations for PREVAIL: Enzalutamide benefits patients with visceral and nonvisceral disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. PREVAIL: Enzalutamide benefits patients with visceral and nonvisceral disease

User login

  • Reset your password
  • /content/prevail-enzalutamide-benefits-patients-visceral-and-nonvisceral-disease
  • /oncologypractice/article/82942/genitourinary-cancer/prevail-enzalutamide-benefits-patients-visceral
  • /hematology-oncology/article/82942/genitourinary-cancer/prevail-enzalutamide-benefits-patients